Entegris, Inc. (BMV:ENTG)

Market Cap	208.79B
Revenue (ttm)	60.75B
Net Income (ttm)	5.57B
Shares Out	n/a
EPS (ttm)	36.75
PE Ratio	37.49
Forward PE	24.80
Dividend	7.89 (0.51%)
Ex-Dividend Date	Jul 30, 2025

Volume	258
Average Volume	1,126
Open	1,550.00
Previous Close	n/a
Day's Range	1,550.00 - 1,550.00
52-Week Range	1,550.00 - 2,216.58
Beta	n/a
RSI	39.53
Earnings Date	Aug 6, 2025

About Blueprint Medicines

Entegris, Inc. provides advanced materials and process solutions for the semiconductor and other high-technology industries in North America, Taiwan, South Korea, Japan, China, Europe, and Southeast Asia. The company operates in two segments, Materials Solutions (MS) and Advanced Purity Solutions (APS). The MS segment provides materials-based solutions, such as chemical vapor and atomic layer deposition materials, chemical mechanical planarization slurries and pads, ion implantation specialty gases, formulated etch and clean materials, and othe...

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1966
• Employees: 8,200
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: ENTG

Financial Performance

In 2024, Entegris's revenue was $3.24 billion, a decrease of -8.02% compared to the previous year's $3.52 billion. Earnings were $292.79 million, an increase of 62.06%.